Raisio Q2 results dip but not beyond expectation

- Last updated on GMT

Related tags: Marketing, Stanol ester, Brand

Raisio, the Finnish ingredients supplier and owner of the Benecol plant stanol cholesterol-lowering range, reports lower sales and profits for the second quarter of 2009, drops the company said it was prepared for.

In line with forecasts made last year as the economic crisis took hold, sales for the quarter ended June 30 dropped 12.4 per cent from €111.6m to €97.8m, while EBIT (earnings before interest and tax) was €4.5m compared to €5.9m in the corresponding quarter last year.

But this figure included one-off costs of €0.8m for an unfinished acquisition.

The company noted it had restructured in 2009, selling off its margarine business and bringing the rest of its business under two umbrellas – Brands and Business to Business.

The Brands division, which includes Benecol, performed well, while Business to Business has struggled.

Chief executive officer, Matti Rihko, said the restructuring reflected a more grain-centric strategy, which was strengthening the company, but predicted volatility ahead.

“We are pleased with these results in what is a very difficult period and are feeling the benefit of our restructuring,”​ he told NutraIngredients.com this morning.

“Brand profitability doubled over the period, and Benecol users are demonstrating a great level of brand loyalty. Business to Business has faced greater challenges with feed and vegetable oil sales down and the situation not helped by the salmonella scare.”

Benecol volumes grew over the period despite the recession, he said.

Volatile markets and results would continue, meaning even if food consumption and demand remain steady, volumes may be reduced in the short run, ”either directly or indirectly, through the food chain infrastructure.”

Volatility in raw material prices was expected to grow.

Rihko predicted “moderate growth”​ in its volumes over the rest of 2009, with positive cash flows, but lower than 2008 levels.

Related news

Show more

Related products

show more

Skin-Gut Axis: The Potential of Pomella®

Skin-Gut Axis: The Potential of Pomella®

Gee Lawson Nutritional - LEHVOSS Group | 02-Nov-2018 | Technical / White Paper

When skin is exposed to oxidative stress, the effectiveness of the endogenic antioxidant system can be significantly compromised. Pomegranate, a natural...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

 Cannabidiol: Should you invest in it?

Cannabidiol: Should you invest in it?

The Whitehouse Consultancy | 17-Oct-2018 | Technical / White Paper

An increasing number of CBD containing products are appearing on the market and consumer interest in this substance is rising.

Decoding the Six Pathways of Ageing

Decoding the Six Pathways of Ageing

Gencor | 04-Oct-2018 | Technical / White Paper

The desire to extend lifespan has been around since the beginning of time and with the growing ageing population, more and more research is being conducted...

Related suppliers

Follow us

Featured Events

View more


View more